Dr. Reddy's Laboratories is targeting to triple its reach to 1.5 billion patients by 2030 as part of its sustainability goals. Under its sustainability goals for the next decade, it is making its products accessible and affordable for patients and 25 per cent of new launches to be first to market by 2027.
Besides, by 2030 the company will use 100 per cent renewable power and it will also be carbon-neutral in direct emissions, while it is targeting 12.5 per cent reduction in indirect carbon emissions.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1889.70 |
| Dr. Reddys Labs. | 1406.75 |
| Cipla | 1477.00 |
| Zydus Lifesciences | 1116.95 |
| Lupin | 2400.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: